Literature DB >> 17034662

Relaxant effect of Crocus sativus (saffron) on guinea-pig tracheal chains and its possible mechanisms.

M H Boskabady1, M R Aslani.   

Abstract

As indicated in ancient Iranian medical books, Crocus sativus has therapeutic effects on respiratory diseases. The relaxant effect of this plant has been observed also on smooth muscles in previous studies. Therefore, in this study the relaxant effects of aqueous-ethanolic extracts of C. sativus and one of its main constituents, safranal, were examined on guinea-pig tracheal chains. The relaxant effects of four cumulative concentrations of aqueous-ethanolic extract (0.15, 0.3, 0.45, and 0.60 g %) and safranal (0.15, 0.30, 0.45, and 0.60 mL 0.2 mg mL(-1) solution) in comparison with saline, as negative control, and four cumulative concentrations of theophylline (0.15, 0.30, 0.45, and 0.60 mM), as positive control, were examined using guinea-pig precontracted tracheal chains. The tracheal chains had been precontracted by three different methods. Group 1 had been precontracted using 10 microM methacholine. The other two groups had been precontracted using 60 mM KCl at two different conditions: non-incubated tissues (group 2) and tissues incubated with 1 microM propranolol, 1 microM chlorpheniramine and 1 microM atropine (group 3) (for each group, n = 6). In group 1 all concentrations of theophylline, extract and safranal showed significant relaxant effects compared with saline (P < 0.05 to P < 0.001). In group 2 theophylline, extract and safranal showed concentration-dependent relaxant effects also compared with saline (P < 0.05 to P < 0.001 for different concentrations except two low concentrations of safranal). However, in group 3 the extracts of C. sativus showed a weak relaxant effect (P < 0.05 only for the highest concentration). The effects of the last concentration of safranal (0.60 mL 0.2 mg mL(-1) solution) in group 1, and all its concentrations in group 2 were significantly lower than those of theophylline (P < 0.05 to P < 0.001). In addition, the effects of safranal 0.45 and 0.60 mL 0.2 mg mL(-1) solution in groups 1 and 2 were significantly lower than that of C. sativus extract. There were significant correlations between the relaxant effects and concentrations for extract, safranal and theophylline in all experimental groups (P < 0.001 for all cases). These results showed a potent relaxant effect of C. sativus on tracheal chains of guinea-pigs that was comparable to or even higher than that of theophylline at the concentrations used. The results indicated that safranal was, at least in part, responsible for the relaxant effect of C. sativus.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17034662     DOI: 10.1211/jpp.58.10.0012

Source DB:  PubMed          Journal:  J Pharm Pharmacol        ISSN: 0022-3573            Impact factor:   3.765


  26 in total

Review 1.  Pharmacokinetic Properties of Saffron and its Active Components.

Authors:  Azar Hosseini; Bibi Marjan Razavi; Hossein Hosseinzadeh
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2018-08       Impact factor: 2.441

Review 2.  Saffron: A potential drug-supplement for severe acute respiratory syndrome coronavirus (COVID) management.

Authors:  Amjad M Husaini; Khan Nadiya Jan; Gowher A Wani
Journal:  Heliyon       Date:  2021-05-14

3.  The effect of chronic administration of safranal on systolic blood pressure in rats.

Authors:  Mohsen Imenshahidi; Bibi Marjan Razavi; Ayyoob Faal; Ali Gholampoor; Seyed Mehran Mousavi; Hossein Hosseinzadeh
Journal:  Iran J Pharm Res       Date:  2015       Impact factor: 1.696

4.  Safranal as a safe compound to mice immune system.

Authors:  Bamdad Riahi-Zanjani; Mahdi Balali-Mood; Elaheh Mohammadi; Hassan Badie-Bostan; Bahram Memar; Gholamreza Karimi
Journal:  Avicenna J Phytomed       Date:  2015 Sep-Oct

Review 5.  Smooth muscle relaxant activity of Crocus sativus (saffron) and its constituents: possible mechanisms.

Authors:  Amin Mokhtari-Zaer; Mohammad Reza Khazdair; Mohammad Hossein Boskabady
Journal:  Avicenna J Phytomed       Date:  2015 Sep-Oct

6.  Cardioprotective effect of saffron extract and safranal in isoproterenol-induced myocardial infarction in wistar rats.

Authors:  Roya Mehdizadeh; Mohammad-Reza Parizadeh; Ali-Reza Khooei; Soghra Mehri; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2013-01       Impact factor: 2.699

7.  The potential effect of the extract of Crocus sativus and safranal on the total and differential white blood cells of ovalbumin-sensitized guinea pigs.

Authors:  G Bayrami; M H Boskabady
Journal:  Res Pharm Sci       Date:  2012-10

8.  Affinity-based target deconvolution of safranal.

Authors:  Hossein Hosseinzadeh; Soghra Mehri; Mohammad Mahdi Abolhassani; Mohammad Ramezani; Amirhossein Sahebkar; Khalil Abnous
Journal:  Daru       Date:  2013-03-20       Impact factor: 3.117

9.  Safranal: from an aromatic natural product to a rewarding pharmacological agent.

Authors:  Ramin Rezaee; Hossein Hosseinzadeh
Journal:  Iran J Basic Med Sci       Date:  2013-01       Impact factor: 2.699

10.  A survey on saffron in major islamic traditional medicine books.

Authors:  Behjat Javadi; Amirhossein Sahebkar; Seyed Ahmad Emami
Journal:  Iran J Basic Med Sci       Date:  2013-01       Impact factor: 2.699

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.